An E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARγ Pro12Ala variant
To the Editor: The search for the Type II (non-insulin-dependent) diabetes mellitus gene(s) has proven to be a challenge. It is still not known whether common or rare variants are involved and if these susceptibility loci will have a single allele altering risk or if combinations of these variants will affect risk. For example, the PPARγ Pro12Ala variant has consistently been shown to be associated with risk of Type II diabetes [1, 2] . We believe that the Kir6.2 E23K SNP should also be considered as a Type II diabetes risk altering polymorphism. Kir6.2 (KCNJII gene on 11p15.1) is a subunit of the inwardly rectifying ATP sensitive K+ channel, which is involved in the regulation of insulin secretion in pancreatic beta cells [3] . We have reported an association between the Kir 6.2 E23K homozygous genotype (KK) and Type II diabetes in a case-control meta-analysis [4] . Most recently, electrophysiological studies in which human isoforms of Kir6.2 in COS-1 cells were used, showed a dose-dependent reduction in ATP sensitivity of the Kir6.2 E23K variant [5] . Hence, we decided to re-evaluate the common E23K polymorphism by genotyping an additional population (Ashkenazi Jewish) and including the United Kingdom Prospective Diabetes Study (UKPDS) data [6] . We assessed the relative risk associated with the (K) allele and the homozygous E23K (KK) status.
In the original study, we analysed 521 Type II diabetic patients and 367 control subjects, where the E23K variant was more frequent in the patients than in the control subjects (0.19 vs 0.11, p=0.0016; corrected p<0.01). All subjects in our study gave their informed consent. In the Ashkenazi sample, the frequency of the KK genotype in the Type II diabetic patients (0.15) compared with the control subjects (0.10) tended in the same direction but was not significant (p=0.097). However, Fig. 1 (Fig. 1A) , which translates into an average attributable risk of 11.4% for the populations surveyed in these studies. This data suggests that if this population were monomorphic for the non-risk allele (E), the prevalence of Type II diabetes would be 11.4% lower in this study group. The KK homozygote is at greatest risk (relative risk =1.28, 95% CI: 1.19 to 1.37) (Fig. 1B) , confirming our original study.
Our purpose was to confirm the importance of the Kir 6.2 E23K polymorphism and estimate the risk associated with this variant to Type II diabetes. Our results indicate that E23K increases susceptibility to Type II diabetes and is comparable to the 25% population attributable risk contributed by PPARγ Pro12 Ala SNP.
